Ljung R C
Pediatric Clinic, University of Malmö, University of Lund, Sweden.
Baillieres Clin Haematol. 1996 Jun;9(2):243-57. doi: 10.1016/s0950-3536(96)80061-8.
Prenatal diagnosis of haemophilia A or B is possible by means of chorionic villus biopsy in the first trimester which traces the mutation or informative genetic markers. If possible, direct gene analysis of the mutation is preferred. The natural starting point in haemophilia A is to ascertain whether the disease is due to inversion in the X-chromosome, which is the case in almost half of the severe cases. In haemophilia B, most families carry a unique mutation which needs to be characterized. In the immediate future, much of the prenatal diagnosis will be based on indirect genetic markers, repeats or polymorphisms, of the F.VIII and IX genes. Today chorionic villus sampling is the most widely used method but amniotic fluid, fetal blood and pre-implantation genetic diagnostics can also be used in selected cases. Prenatal diagnosis must be preceded by adequate genetic counselling and risk assessment of the potential carrier and subsequent support during the diagnostic process.
通过孕早期的绒毛取样追踪突变或信息性遗传标记,可对甲型或乙型血友病进行产前诊断。若有可能,首选对突变进行直接基因分析。对于甲型血友病,自然的起始点是确定疾病是否由X染色体倒位引起,几乎一半的重症病例都是这种情况。对于乙型血友病,大多数家族携带独特的突变,需要进行特征描述。在不久的将来,大部分产前诊断将基于凝血因子VIII和IX基因的间接遗传标记、重复序列或多态性。如今,绒毛取样是使用最广泛的方法,但在特定情况下也可使用羊水、胎儿血液和植入前基因诊断。产前诊断之前必须进行充分的遗传咨询以及对潜在携带者的风险评估,并在诊断过程中提供后续支持。